Fundz

Novartis Enters Agreement Worth Up to $7.8 Billion with Abogen Biosciences for mRNA-based T Cell Engager Development.

Oct 02, 2026

Contract Type

agreement

SwitzerlandBiotechnologyHealth Carepharmaceuticals

Description

Novartis has formed an agreement with China's Abogen Biosciences involving an upfront payment of $575 million and potential milestone payments totaling up to $7.2 billion. This partnership focuses on developing ABO2203, an mRNA candidate aimed at improving T cell engager safety for patients with autoimmune diseases.

Company Information

Company

Novartis

Location

2 Fabrikstrasse

Switzerland

About

Novartis India Ltd is a subsidiary of Novartis AG, focusing on healthcare products for chronic conditions. The company has a diverse portfolio including diabetes, neurology, and cardiology therapies. It operates in the Indian pharmaceutical market with a robust revenue stream. Novartis India aims to provide innovative solutions in healthcare.

Related People

Shreeram
Senior decision-maker at this company
••••••••@••••••••

See Shreeram's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Novartis's next move

Learn about Strategic plan

Novartis signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.